You have 9 free searches left this month | to do more

venetoclax

Venetoclax is a drug used to treat Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and other conditions. Venetoclax is being actively studied in 227 studies and prior, has been studied in 21.

Top SponsorsTop SitesTop Investigators
AbbVieM D Anderson Cancer CenterMatthew S. Davids, MD
M.D. Anderson Cancer CenterDana Farber Cancer InstitutePaolo Ghia
Hoffmann-La RocheMD Anderson Cancer CenterAndrew Lane
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-10-27
Oct 27, 2021
N
Recruiting
  • Chronic Lymphocytic Leukemia
  • Venetoclax
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-10-27
Oct 27, 2021
D
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-09-08
Sep 8, 2021
U
Recruiting
  • Chronic Lymphocytic Leukemia
  • San Diego, California
    UCSD Koman Family Outpatient Pavilion
2021-11-24
Nov 24, 2021
D
Recruiting
  • Waldenstrom Macroglobulinemia
  • MYD88 Gene Mutation
  • Boston, Massachusetts
  • +1 more
2021-11-15
Nov 15, 2021
K
Withdrawn
  • Chronic Lymphocytic Leukemia
  • Loss of Chromosome 17p
  • (no location specified)
2021-10-29
Oct 29, 2021
U
Not yet recruiting
  • Myeloproliferative Neoplasm
  • BCR-ABL Negative
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-09-29
Sep 29, 2021
D
Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-09-08
Sep 8, 2021
D
Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-11-02
Nov 2, 2021
C
Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Venetoclax
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
2021-12-30
Dec 30, 2021
K
Suspended
  • Primary CNS Lymphoma
  • Stuttgart, Baden-Württemberg, Germany
    Klinikum Stuttgart
2021-09-15
Sep 15, 2021
H
Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • Helsinki, Uusimaa, Finland
    HelsinkiUCH
2021-08-24
Aug 24, 2021
L
Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
2021-12-21
Dec 21, 2021
N
Recruiting
  • Chronic Lymphocytic Leukemia
  • Venetoclax
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-01-06
Jan 6, 2022
C
Suspended
  • Leukemia
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2021-12-29
Dec 29, 2021
D
Recruiting
  • Leukemia
  • Venetoclax
  • Standard Chemotherapy
  • Boston, Massachusetts
  • +1 more
2021-08-02
Aug 2, 2021
D
Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
  • +1 more
2021-10-19
Oct 19, 2021
A
Available
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Venetoclax
  • (no location specified)
2021-05-24
May 24, 2021
J
Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
2021-12-09
Dec 9, 2021
C
Suspended
  • Non-hodgkin Lymphoma
  • Venetoclax
  • Cleveland, Ohio
  • +1 more
2021-11-03
Nov 3, 2021
H
Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • Hannover, Niedersachsen, Germany
    Medical School Hannover
2021-02-15
Feb 15, 2021
U
Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Edmonton, Alberta, Canada
  • +1 more
2021-11-29
Nov 29, 2021
O
Recruiting
  • Chronic Lymphocytic Leukemia
  • Ibrutinib Resistance
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-10-29
Oct 29, 2021